Sanofi Board of Directors Provides Update
Paris, France - September 6, 2016 - Sanofi's Board of Directors was informed by Bonnie L. Bassler that she wished to resign as a Director of Sanofi due to a potential conflict of interest related to her impending membership on another board. Accordingly, her resignation was accepted, effective September 6th.
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
| Media Relations |
Tel. : +33 (0)1 53 77 46 46
| Investor Relations |
Tel.: +33 (0)1 53 77 45 45